Reporting Manager
Alyeska Investment Group, L.P.
Symbol
CABA
Shares outstanding
89,943,101 shares
Disclosed Ownership
8,904,367 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
14 Aug 2025, 17:29:13 UTC
Date of event
30 Jun 2025
Next filing
14 Nov 2025

Quoteable Key Fact

"Alyeska Investment Group, L.P. disclosed 9.9% ownership in CABALETTA BIO, INC. Common Stock, par value $0.00001 per share (CABA) on 30 Jun 2025."

Quick Takeaways

  • Alyeska Investment Group, L.P. filed SCHEDULE 13G for CABALETTA BIO, INC. Common Stock, par value $0.00001 per share (CABA).
  • Disclosed ownership: 9.9%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Aug 2025, 17:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Alyeska Investment Group, L.P. 9.9% 8,904,367 0 8,904,367 Jason Bragg Jason Bragg | Chief Financial Officer
Alyeska Fund GP, LLC 9.9% 8,904,367 0 8,904,367 Jason Bragg Jason Bragg | Chief Financial Officer
Anand Parekh 9.9% 8,904,367 0 8,904,367 Anand Parekh Anand Parekh | Self